Mapping Which Coronavirus Variants Will Resist Antibody TreatmentsPosted on February 9th, 2021 by Dr. Francis CollinsCaption: The antibody LY-CoV016 (purple) is bound to RBD. In the study, researchers mapped all possible mutations that would allow SARS-CoV-2 to resist treatment with three different monoclonal antibodies developed for treatment of COVID-19 . Their studies show most of the mutations that would allow SARS-CoV-2 to escape treatment differed between the two Regeneron antibodies. The researchers also looked to data from all known circulating SARS-CoV-2 variants as of Jan. 11, 2021, for evidence of escape mutations. Reference: Prospective mapping of viral mutations that escape antibodies used to treat COVID-19.
At Wellness Axis we want to encourage habits of wellness, Increase awareness of factors and resources contributing to well-being, Inspire and empower individuals to take responsibility for their own health, and to support a sense of community. Wellness can be thought of as the quality or state of being in good health.